NeuroPace logo
NeuroPace
NPCE | NASDAQ
Chart Builder DCF Calculator
$7.97
+$0.41 (+5.42%)
At close: Nov 16, 2026, 4:00 PM ET
$7.82
-$0.15 (-1.88%)
After-hours: Nov 16, 2026, 7:39 PM ET

NeuroPace Company Profile

Company profile explained

Company Profile

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Key Executives

Name Position
Joel D. Becker Chief Executive Officer, President & Director
Patrick F. Williams Chief Financial Officer
Amy Treadwell Vice President of Human Resources
Chris Reese Senior Vice President of Sales
Dylan John Chief of Operations & Development
Julie Hsu Vice President & Controller
Katie Keller Vice President of Marketing
Leah Akin General Counsel & Corporate Secretary
Martha J. Morrell Chief Medical Officer
Scott R. Schaper Head of Investor Relations

Latest SEC Filings

Date Type Title
Sep 25, 2026 4 Filing
Sep 21, 2026 4 Filing
Sep 04, 2026 4 Filing
Sep 04, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 28, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 11, 2026 10-Q Quarterly Report
Aug 11, 2026 8-K Current Report
Jul 28, 2026 8-K Current Report
View All SEC Filings ➞
NeuroPace
NeuroPace logo
Country United States
IPO Date Apr 22, 2021
Industry Medical - Devices
Sector Healthcare
Employees 220
CEO Joel D. Becker

Contact Details

455 North Bernardo Avenue Mountain View, California 94043 United States

Stock Details

Ticker Symbol NPCE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001528287
CUSIP Number 641288105
ISIN Number US6412881053
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.